-
2023-504486-23-00
5
2024-05-29
Venous thromboembolism
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2022-500717-64-00
4
2023-12-27
cardiac arrest
-
2022-500974-33-00
5
2023-08-12
acute venous thromboembolism event
-
2024-515945-40-00
10
2022-05-02
Non small cell lung cancer
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2024-516421-30-00
4
2020-02-05
Neonatal hypoxic-ischaemic encephalopathy
-
2023-507256-76-00
6
2020-01-14
Ulcerative colitis
-
2024-514362-39-00
4
2019-12-05
Diabetic macular oedema
-
2023-508359-38-00
5
2024-06-05
Early-stage Non-squamous Non-small Cell Lung Cancer
-
2023-506988-34-00
5
2024-03-27
Heart failure with mildly reduced or preserved ejection fraction and s
-
2023-505972-32-00
5
2024-02-26
locally advanced anal squamous cell carcinoma
-
2023-503827-25-01
5
2024-02-16
Non-Small Cell Lung Cancer (NSCLC)
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2023-509825-38-00
5
2022-12-01
Metastatic Non–Small Cell Lung Cancer
-
2024-514703-34-00
5
2020-09-08
Thromboembolic event
-
2024-515946-17-00
5
2019-07-22
Non Small Cell Lung Cancer
-
2024-513964-24-00
5
2017-09-14
Squamous cell carcinoma, previously untreated
Stage III, stage IVa (op
-
2024-517622-25-00
5
2013-12-06
Patients with localized prostate cancer and high-risk features of rela
-
2024-511057-22-00
5
2024-12-04
Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
-
2023-505108-52-00
5
2023-12-20
Intensive Care
-
2023-504112-15-00
4
2023-01-04
Metastatic Non-Small Cell Lung Cancer